compounds for inhibition of cell proliferation in egfr-driven cancers, method and pharmaceutical composition

摘要

The invention features compounds, pharmaceutical compositions and methods for treating patients who have an EGFR-driven cancer of formula I: wherein the variables are as defined herein.